{
    "2019-04-08": [
        [
            {
                "time": "",
                "original_text": "建议关注医药国改机会，港股医药配置价值凸显｜【光大医药·周报】",
                "features": {
                    "keywords": [
                        "医药",
                        "国改",
                        "港股",
                        "配置价值"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "券商投资路线图曝光：重仓61只个股",
                "features": {
                    "keywords": [
                        "券商",
                        "投资路线图",
                        "重仓",
                        "个股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}